Source: Kane Biotech, Inc.


Kane Biotech Inc., a biotechnology company engaged in the development of products that prevent and disperse microbial biofilms, has invented biotech plants producing DispersinB antibiofilm enzyme. This provides a proof of concept for developing bacterial disease resistant agricultural crops of economic importance.


"Just like humans and animals, plants must constantly fight against bacterial infections, which account for billions of dollars of losses in crop yields and quality annually. The genetic engineering of plants will help defend against these pathogens and have a large impact on agricultural productivity. In 2009, 14 million farmers in 25 countries grew biotech crops on 134 million hectares generating $10.5 billion in seed/licensing revenues," stated Gord Froehlich, president and chief executive officer of Kane Biotech.


Original press release